Does Lutetium177 increase survival
177Lu-PSMA-617 RLT seems to prolong survival in patients with advanced mCRPC pretreated with chemotherapy, abiraterone and/or enzalutamide.
This article appeared today in Health Unlocked.
To see the article click on the following link - https://tinyurl.com/y7yolyaf